Genesis IBRC India [GENESIS] vs OneSource Specialty [ONESOURCE] Detailed Stock Comparison

Genesis IBRC India Ltd.

BSE
Loading...

OneSource Specialty Pharma Inc.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Genesis IBRC India Ltd. wins in 8 metrics, OneSource Specialty Pharma Inc. wins in 6 metrics, with 1 ties. Genesis IBRC India Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Genesis IBRC India Ltd. OneSource Specialty Pharma Inc. Better
P/E Ratio (TTM) 57.89 936.63 Genesis IBRC India Ltd.
Price-to-Book Ratio 9.93 3.11 OneSource Specialty Pharma Inc.
Debt-to-Equity Ratio 0.00 21.93 Tie
PEG Ratio N/A 42.24 N/A
EV/EBITDA 26.95 40.79 Genesis IBRC India Ltd.
Profit Margin (TTM) 2.36% 1.42% Genesis IBRC India Ltd.
Operating Margin (TTM) -11.05% -18.02% Genesis IBRC India Ltd.
Return on Equity 0.08% -0.31% Genesis IBRC India Ltd.
Return on Assets (TTM) 0.05% -0.24% Genesis IBRC India Ltd.
Free Cash Flow (TTM) $-3,000 $-1.96B Genesis IBRC India Ltd.
1-Year Return 507.27% -5.07% Genesis IBRC India Ltd.
Price-to-Sales Ratio (TTM) 1,399.83 13.01 OneSource Specialty Pharma Inc.
Enterprise Value $944.70M $195.90B OneSource Specialty Pharma Inc.
EV/Revenue Ratio 326.10 13.80 OneSource Specialty Pharma Inc.
Gross Profit Margin (TTM) N/A 67.50% N/A
Revenue per Share (TTM) $0 $124 OneSource Specialty Pharma Inc.
Earnings per Share (Diluted) $-0.18 $1.72 OneSource Specialty Pharma Inc.

Genesis IBRC India Ltd. vs OneSource Specialty Pharma Inc. Stock Performance Analysis

Loading Price Chart...

GENESIS
ONESOURCE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Genesis IBRC India Ltd.-4.96%0.00%-0.51%54.94%-14.33%37.72%
OneSource Specialty Pharma Inc.-0.99%1.27%4.12%39.64%12.39%2.29%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Genesis IBRC India Ltd.507.27%993.55%1,467.02%623.84%5,745.00%5,745.00%
OneSource Specialty Pharma Inc.-5.07%6.70%6.70%6.70%6.70%6.70%

Performance & Financial Health Analysis: Genesis IBRC India Ltd. vs OneSource Specialty Pharma Inc.

MetricGENESISONESOURCE
Market Information
Market Cap i₹4.47B₹202.76B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2501,038,625
90 Day Avg. Volume i317610,058
Last Close₹111.10₹1,810.50
52 Week Range₹19.25 - ₹181.30₹1,057.00 - ₹2,248.00
% from 52W High-38.72%-19.46%
All-Time High₹184.90 (Nov 11, 2025)₹2,248.00 (Jun 18, 2025)
% from All-Time High-39.91%-19.46%
Growth Metrics
Quarterly Revenue GrowthN/A-0.26%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.02%0.01%
Operating Margin (TTM) i-0.11%-0.18%
Return on Equity (TTM) i0.00%0.00%
Debt to Equity (MRQ) i0.0021.93
Cash & Liquidity
Book Value per Share (MRQ)₹9.02₹518.08
Cash per Share (MRQ)₹5.26₹14.56
Operating Cash Flow (TTM) i₹0₹-2,152,760,000
Levered Free Cash Flow (TTM) i₹35.05M₹-179,710,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Genesis IBRC India Ltd. vs OneSource Specialty Pharma Inc.

MetricGENESIS (Apr 24, 2026)ONESOURCE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i57.89936.63
Forward P/E iN/A42.24
PEG Ratio iN/A42.24
Price to Sales (TTM) i1,399.8313.01
Price to Book (MRQ) i9.933.11
Market Capitalization
Market Capitalization i₹4.47B₹202.76B
Enterprise Value i₹944.70M₹195.90B
Enterprise Value Metrics
Enterprise to Revenue i326.1013.80
Enterprise to EBITDA i26.9540.79
Risk & Other Metrics
Beta iN/AN/A
Book Value per Share (MRQ) i₹9.02₹518.08

Financial Statements Comparison: Genesis IBRC India Ltd. vs OneSource Specialty Pharma Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGENESIS (2025)ONESOURCE (2025)
Revenue/Sales i014.45B
Cost of Goods Sold i04.35B
COGS % of Revenue i-30.1%
Gross Profit i010.10B
Gross Margin i-69.9%
Research & Development iN/A20.49M
Operating Income (EBIT) i35.05M1.90B
Operating Margin i-13.2%
EBITDA i35.05M4.71B
EBITDA Margin i-32.6%
Pre-Tax Income i35.05M-670.66M
Pre-Tax Income % of Revenue i--4.6%
Income Tax i0-497.85M
Income Tax % of Revenue i--3.4%
Net Income (Profit) i35.05M-179.71M
Profit Margin i--1.2%

Balance Sheet & Liquidity Metrics

MetricGENESIS (2025)ONESOURCE (2025)
Cash & Equivalents i57,0001.56B
Total Current Assets i88.35M10.86B
Total Current Assets % of Revenue i-75.2%
Total Current Liabilities i3.03M11.14B
Total Current Liabilities % of Revenue i-77.1%
Long-Term Debt iN/A3.83B
Long-Term Debt % of Revenue i-26.5%
Total Shareholders Equity i85.33M58.81B
Retained Earnings i-83.06M-18.43B
Retained Earnings % of Revenue i--127.6%
Property, Plant & Equipment iN/A8.97B

Cash Flow Statement Comparison

MetricGENESIS (2025)ONESOURCE (2025)
Operating Cash Flow i0-2.15B
Operating Cash Flow % of Revenue i--14.9%
Capital Expenditures iN/AN/A
Free Cash Flow i-3,000-1.96B
FCF Margin i--13.6%
Debt Repayment iN/A-6.31B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGENESISONESOURCE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i45.25M114.64M
Float Shares iN/A70.43M
% Held by Insiders i27.24%38.63%
% Held by Institutions i0.00%26.67%
% Held by Public i72.76%34.70%

Dividend Analysis & Yield Comparison: Genesis IBRC India Ltd. vs OneSource Specialty Pharma Inc.

MetricGENESISONESOURCE
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A